Generate Biomedicines (GENB) EV/EBIT: History & Chart

Generate Biomedicines, Inc.(GENB)

Biotechnology · Somerville, MA

$13.66-0.25 (-1.80%)

Delayed quote: Oct 6, 2026, 10:40 AM EDT

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Somerville, MA

312 employees

generatebiomedicines.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael T. Nally

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Generate Biomedicines, Inc. (GENB)	$1.75B	N/A	N/A	N/A	N/A
Alignment Healthcare, Inc. (ALHC)vs ›	$1.73B	24.79x	614.86x	614.86x	614.86x
DENTSPLY SIRONA Inc. (XRAY)vs ›	$1.73B	8.92x	16.91x	16.91x	19.03x
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.71B	N/A	N/A	N/A	N/A
Absci Corporation (ABSI)vs ›	$1.79B	N/A	N/A	N/A	N/A
Novocure Ltd (NVCR)vs ›	$1.81B	N/A	783.33x	1393.80x	1393.80x
LeMaitre Vascular, Inc. (LMAT)vs ›	$1.83B	25.72x	35.10x	39.10x	37.80x
Astrana Health, Inc. (ASTH)vs ›	$1.84B	24.09x	27.59x	23.49x	21.15x
Agios Pharmaceuticals, Inc. (AGIO)vs ›	$1.86B	N/A	N/A	N/A	N/A
Novavax, Inc. (NVAX)vs ›	$1.85B	N/A	3.63x	3.63x	3.63x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Generate Biomedicines, Inc. (GENB)

$1.75B

N/A

Alignment Healthcare, Inc. (ALHC)vs ›

$1.73B

24.79x

614.86x

DENTSPLY SIRONA Inc. (XRAY)vs ›